Maquet Medical Systems USA announced the availability of its two new intensive care ventilators, SERVO-U, and its dedicated neonatal intensive care solution, SERVO-n. SERVO-U and SERVO-n were cleared by the U.S. Food and Drug Administration in December 2015.
SERVO-U represents the next step to making protective ventilation more accessible, understandable and
easy to implement, putting solutions at clinicians’ fingertips to support the delivery of tailored patient care.
At the foundation of SERVO-U is a completely touch-based interface that empowers users to manage ventilation in a highly intuitive and timesaving manner. The platform, which can be used on neonates through adults, supports efficient workflow in the fast-paced intensive care environment through on-screen, context-based guidance and clinical support tools that help facilitate the implementation of the various ventilation protocols. Available on each SERVO-U are innovative technologies such as NAVA (Neurally Adjusted Ventilatory Assist) and Edi monitoring for enhanced patient-ventilator interaction and greater insight into patient respiratory condition.
In addition to the solutions that SERVO-U brings to patients and clinicians, the platform is designed to grow with the customer. When patient needs change or new functionalities become available, SERVO-U can be upgraded easily and cost-effectively.
The intuitive ventilation platform is the result of a comprehensive development process that involved collaboration with intensive care experts from around the world. The launch of SERVO-U marks the latest offering in Maquet Medical System’s SERVO franchise which has been a longstanding leader in the global mechanical ventilation market.
SERVO-n was created to help clinicians provide vulnerable neonatal and infant patients with the support they need while protecting the lungs, brain, and other developing organs.
SERVO-n is both sensitive and responsive in conventional modes of ventilation and compensates for variable leakage. New hot-wire anemometer flow sensor technology works in conjunction with the internal sensor of the SERVO-n to trigger, measure and deliver the desired pressure levels and tidal volumes down to 2ml. SERVO-n also includes both Neurally Adjusted Ventilatory Assist (NAVA) and non-invasive NAVA modes as standard to help clinicians match respiratory support to the often irregular breathing patterns of neonates, resulting in less work of breathing, lower peak pressures and FiO2 requirements, and improved comfort.
Both Maquet’s SERVO-U and SERVO-n are recipients of the prestigious Medical Design Excellence Award’s (MDEA) Gold Award in the “Critical Care and Emergency Medicine Products” category for 2015. The awards were part of the 2015 MDEA’s highly competitive international competition.
Maquet Medical Systems